EXPANDED ACCESS PROGRAM (EAP) FOR LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Palumbo, A. [1 ]
Gay, F. [1 ]
Buda, G. [2 ]
Guglielmelli, T. [2 ]
Perrone, G. [2 ]
Corradini, P. [3 ]
Benedetti, F. [2 ]
Offidani, M. [2 ]
Rossi, D. [2 ]
Gozzetti, A. [2 ]
Catalano, L. [2 ]
Canepa, L. [4 ]
Di Raimondo, F. [5 ]
Patriarca, F. [2 ]
Petrucci, M. T. [2 ]
Di Renzo, N. [2 ]
Galli, M. [2 ]
Cavallo, F. [1 ]
Bringhen, S. [1 ]
Boccadoro, M. [1 ]
机构：
[1] AOU San Giovanni Battista, Turin, Italy
[2] Italian Multiple Myeloma Network, Gimema, Italy
[3] Ist Nazl Tumori, Div Ematol, I-20133 Milan, Italy
[4] Univ Genoa, Osp San Martino, Clin Ematol, Genoa, Italy
[5] Osped Ferrarotto, Cattedra Ematol, Catania, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0639
引用
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [1] Expanded access program (EAP) for lenalidomide (Revlimid®) plus dexamethasone in over 1400 subjects with relapsed or refractory multiple myeloma.
    Chen, Christine
    Reece, Donna E.
    Siegel, David
    Niesvizky, Ruben
    Boccia, Ralph Vincent
    Stadtmauer, Edward A.
    Abonour, Rafat
    Irwin, David
    Polikoff, Jonathan
    Kumar, Shaji
    Gams, Richard A.
    Kenvin, Laurie
    McElveen, Dale
    Hu, Angela
    Pietronigro, Dennis
    Knight, Robert D.
    Zeldis, Jerome B.
    [J]. BLOOD, 2006, 108 (11) : 1015A - 1016A
  • [2] Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
    Chen, Christine
    Reece, Donna E.
    Siegel, David
    Niesvizky, Ruben
    Boccia, Ralph V.
    Stadtmauer, Edward A.
    Abonour, Rafat
    Richardson, Paul
    Matous, Jeffrey
    Kumar, Shaji
    Bahlis, Nizar J.
    Alsina, Melissa
    Vescio, Robert
    Coutre, Steven E.
    Pietronigro, Dennis
    Knight, Robert D.
    Zeldis, Jerome B.
    Rajkumar, Vincent
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) : 164 - 170
  • [3] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Spencer, Andrew
    Attal, Michael
    Prince, H. Miles
    Harousseau, Jean-Luc
    Dmoszynska, Anna
    San Miguel, Jesus
    Hellmann, Andrzej
    Facon, Thierry
    Foa, Robin
    Corso, Alessandro
    Masliak, Zvenyslava
    Olesnyckyj, Marta
    Yu, Zhinuan
    Patin, John
    Zeldis, Jerome B.
    Knight, Robert D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
  • [4] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Dabkara, Deepak
    Bajpai, Jyoti
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13
  • [5] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
  • [6] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Munshi, Nikhil C.
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375
  • [7] Erratum: Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 493 - 493
  • [8] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
    Shinsuke Iida
    Takaaki Chou
    Shinichiro Okamoto
    Hirokazu Nagai
    Kiyohiko Hatake
    Hirokazu Murakami
    Toshiyuki Takagi
    Kazuyuki Shimizu
    Henry Lau
    Kenichi Takeshita
    Masaaki Takatoku
    Tomomitsu Hotta
    [J]. International Journal of Hematology, 2010, 92 : 118 - 126
  • [9] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
    Iida, Shinsuke
    Chou, Takaaki
    Okamoto, Shinichiro
    Nagai, Hirokazu
    Hatake, Kiyohiko
    Murakami, Hirokazu
    Takagi, Toshiyuki
    Shimizu, Kazuyuki
    Lau, Henry
    Takeshita, Kenichi
    Takatoku, Masaaki
    Hotta, Tomomitsu
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (01) : 118 - 126
  • [10] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
    Shin, Junghoon
    Lee, Je-Jung
    Kim, Kihyun
    Min, Chang-Ki
    Lee, Jeong-Ok
    Suh, Cheolwon
    Kim, Jin Seok
    Lee, Yoo Jin
    Yoon, Sung-Soo
    Jo, Jae-Cheol
    Lee, Ho Sup
    Bang, Soo-Mee
    Lee, Jeong-Ok
    Bang, Soo-Mee
    Lee, Je-Jung
    Kim, Kihyun
    Min, Chang-Ki
    Suh, Cheolwon
    Yoon, Dok Hyun
    Kim, Jin Seok
    Lee, Yoo Jin
    Moon, Joon Ho
    Yoon, Sung-Soo
    Kim, Inho
    Jo, Jae-Cheol
    Lee, Ho Sup
    Park, Seong Kyu
    Shin, Ho-Jin
    Kim, Min Kyoung
    Mun, Yeung-Chul
    Lee, Mark Hong
    Park, Yong
    Eom, Hyeon Seok
    Kim, Hyo Jung
    Im, Sung Nam
    Kim, Sung-Hyun
    Do, Young Rok
    Lee, Won Sik
    Cho, Su-Hee
    Yi, Jun Ho
    Lee, Jae Hoon
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 79 - 90
12345